|
|
|
Insider
Information: |
Tang Kevin C |
Relationship: |
Director, 10% Owner |
City: |
Durham |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
1,283,539 |
|
Indirect Shares
|
16,080,253 |
|
|
Direct
Value |
$71,538,178 |
|
|
Indirect Value
|
$20,175,125 |
|
|
Total
Shares |
17,363,792 |
|
|
Total
Value |
$91,713,303 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
Director |
2008-12-15 |
6,300 |
2008-12-15 |
4,100 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2012-06-19 |
0 |
2012-06-19 |
0 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2006-10-23 |
25,000 |
2006-10-23 |
304,736 |
Premium* |
|
Questcor Pharmaceuticals Inc |
QCOR |
10% Owner |
|
0 |
2007-11-13 |
6,718,860 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-04-02 |
27,000 |
2008-04-02 |
3,238,400 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2013-07-12 |
1,218,298 |
|
0 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
Director |
2019-10-04 |
6,941 |
2019-10-04 |
5,814,157 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
Director, 10% Owner |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
26 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.39 |
$648,237 |
I/I |
50,000 |
130,000 |
2.1 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-14 |
4 |
B |
$13.04 |
$431,000 |
I/I |
33,000 |
163,000 |
2.1 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2005-09-08 |
4 |
B |
$11.35 |
$505,963 |
I/I |
44,500 |
6,300 |
2.1 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2005-09-09 |
4 |
B |
$11.94 |
$895,500 |
I/I |
75,000 |
252,800 |
2.1 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2005-09-12 |
4 |
B |
$12.02 |
$938,762 |
I/I |
78,100 |
330,900 |
2.1 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2006-02-24 |
4 |
B |
$3.35 |
$269,377 |
I/I |
80,411 |
17,442 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2006-02-24 |
4 |
B |
$3.35 |
$50,548 |
D/D |
15,089 |
15,089 |
3.92 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2006-02-28 |
4 |
B |
$3.40 |
$34,000 |
I/I |
10,000 |
27,442 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2006-03-17 |
4 |
B |
$3.40 |
$3,400 |
I/I |
1,000 |
686,677 |
2.17 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2006-03-20 |
4 |
B |
$3.45 |
$1,725 |
I/I |
500 |
687,177 |
2.17 |
- |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2006-10-23 |
4 |
B |
$1.52 |
$169,830 |
I/I |
111,686 |
304,736 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-03-27 |
4 |
B |
$1.55 |
$69,278 |
I/I |
44,794 |
2,220,700 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-03-28 |
4 |
B |
$1.57 |
$251,008 |
I/I |
160,000 |
2,380,700 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-03-31 |
4 |
B |
$1.56 |
$29,655 |
I/I |
19,000 |
2,399,700 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-01 |
4 |
B |
$1.67 |
$117,194 |
I/I |
70,000 |
2,469,700 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-02 |
4 |
B |
$1.71 |
$898,333 |
I/I |
525,700 |
2,995,400 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
Director |
|
2019-10-04 |
4 |
B |
$17.50 |
$4,999,995 |
I/I |
285,714 |
5,799,810 |
2.1 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2012-06-19 |
4 |
D |
$32.00 |
$482,848 |
D/D |
(15,089) |
0 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2012-06-19 |
4 |
D |
$32.00 |
$121,620,288 |
I/I |
(3,800,634) |
0 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Director |
|
2022-08-22 |
4 |
D |
$6.23 |
$59,857,429 |
I/I |
(9,607,934) |
0 |
0 |
- |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2006-04-05 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,726,400 |
|
- |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2006-04-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,955,000 |
|
- |
|
QCOR |
Questcor Pharmaceuticals ... |
10% Owner |
|
2007-11-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,718,860 |
|
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-03-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,418,906 |
|
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2013-07-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,218,298 |
|
- |
|
26 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|